Erythrocin Lactobionate

What Is Erythromycin Lactobionate I.V.?

Erythromycin Lactobionate I.V. is an antibiotic used to treat various types of infections. Erythromycin Lactobionate I.V. is available in generic form.

Dosage for Erythromycin Lactobionate I.V.

Common side effects of Erythromycin Lactobionate I.V. include:

• nausea
• vomiting
• diarrhea or loose stools
• stomach pain, and
• pain or redness at the injection site

Dosage for MoviPrep

For the treatment of severe infections in adults and pediatric patients, the recommended intravenous dose of erythromycin lactobionate is 15 to 20 mg/kg/day. Higher doses, up to 4 g/day, may be given for severe infections.

What Drugs, Substances, or Supplements Interact with MoviPrep?

Erythromycin lactobionate may interact with

• theophylline,
• carbamazepine,
• digoxin,
• oral anticoagulants,
• antihistamines,
• cyclosporine,
• hexobarbital,
• phenytoin,
• alfentanil,
• disopyramide,
• lovastatin,
• bromocriptine,
• valproate,
• terfenadine, and
• astemizole

Tell your doctor all medications and supplements you use.

MoviPrep During Pregnancy and Breastfeeding

During pregnancy, erythromycin lactobionate should be used only if prescribed. Erythromycin lactobionate passes into breast milk. Nursing women should exercise caution. Consult your doctor before breastfeeding.

Additional Information

Our Erythromycin Lactobionate I.V. Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Erythrocin Lactobionate Consumer Information

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Call your doctor at once if you have:

• severe stomach pain, diarrhea that is watery or bloody (even if it occurs months after your last dose);
• headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
• a seizure;
• hearing problems (rare);
• pancreatitis--severe pain in your upper stomach spreading to your back, nausea and vomiting; or
• liver problems--loss of appetite, stomach pain (upper right side), tiredness, easy bruising or bleeding, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Serious side effects may be more likely in older adults, including hearing loss, or a life-threatening fast heart rate.

Call your doctor if a baby using this medicine is vomiting or irritable with feeding.

Common side effects may include:

• severe stomach pain, diarrhea that is watery or bloody (even if it occurs months after your last dose);
• liver problems; or
• abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Erythrocin Lactobionate (Erythromycin Lactobionate)

 

Erythrocin Lactobionate Professional Information

SIDE EFFECTS

Erythromycin has been associated with QT prolongation and ventricular arrhythmias, including ventricular tachycardia and torsades de pointes (See WARNINGS).

Side effects following the use of intravenous erythromycin are rare. Occasional venous irritation has been encountered, but if the infusion is given slowly, in dilute solution, preferably by continuous intravenous infusion or intermittent infusion in no less than 20 to 60 minutes, pain and vessel trauma are minimized.

Allergic reactions ranging from urticaria to anaphylaxis have occurred. Skin reactions ranging from mild eruptions to erythema multiforme, Stevens- Johnson syndrome, and toxic epidermal necrolysis have been reported rarely.

There have been isolated reports of reversible hearing loss occurring chiefly in patients with renal insufficiency and in patients receiving high doses of erythromycin.

Elderly patients, particularly those with reduced renal or hepatic function, may also be at increased risk for developing this effect when Erythrocin™ doses of 4 grams/day or higher are given (See DOSAGE AND ADMINISTRATION).

Read the entire FDA prescribing information for Erythrocin Lactobionate (Erythromycin Lactobionate)